Fundamental dimension Equity attribute | ESIPeer $33.21▲+0.30% Cap $8.09BP/E 39.3x QuantScore40/100 | AEISLeader $216.63▼-0.00% Cap $8.68BP/E 37.5x QuantScore57/100 | ASYSPeer $12.42▲+0.65% Cap $217.5MP/E 45.5x QuantScore48/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
25/100 |
23/100 |
16/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 38/100 | 55/100 |
Health Piotroski, Altman Z, leverage & liquidity | 50/100 | 76/100 | 83/100 |
Growth Revenue / earnings growth & margins | 31/100 | 60/100 | 16/100 |
Sentiment Analyst ratings, targets & revisions | 60/100 | 89/100 | 71/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 39.3x | 37.5x | 45.5x |
Forward P/E (next FY) | 18.0x | 19.2x | 38.8x |
EV / EBITDA (TTM) | 21.4x | 25.8x | 17.8x |
Price / Sales | 2.3x | 4.3x | 2.7x |
Price / Free Cash Flow | 45.8x | 100.1x | 24.9x |
PEG ratio | -2.78 | 0.24 | 0.19 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 6 / 9 | 6 / 9 |
Altman Z-Score | 2.42 (Grey) | 4.63 (Safe) | 3.95 (Safe) |
Total debt / equity | 0.72 | 0.95 | 0.15 |
Quick ratio | 2.1x | 2.9x | 4.5x |
Interest coverage | 5.0x | 18.4x | 264.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +3.8% | +21.4% | -21.6% |
Net income growth YoY | -21.9% | +173.7% | -257.4% |
Gross margin (TTM) | 36.6% | 39.7% | 46.9% |
Operating margin (FY) | 13.4% | 10.9% | -35.9% |
FCF margin (FY) | 8.9% | 7.0% | 8.7% |
5. Trailing price performancePrice change over period |
1M return | -3.7% | -22.1% | -19.4% |
3M return | -11.3% | -28.7% | -21.8% |
6M return | -17.7% | -44.1% | -33.8% |
Year to date | +32.9% | +3.5% | -1.0% |
1Y return | +26.9% | +6.9% | +59.0% |
3Y return | +81.0% | +138.6% | +73.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $16.91 -49.1% premium | $58.26 -73.1% premium | $-2.83 -122.8% premium |
Wall Street consensus target | $48.10 +44.8% · range $44.00–$55.00 | $436.75 +101.6% · range $380.00–$535.00 | $22.00 +77.1% · range $22.00–$22.00 |
Consensus stance | 49% Buy34% Hold17% Sell | 70% Buy26% Hold4% Sell | 56% Buy33% Hold11% Sell |